Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
51 Leser
Artikel bewerten:
(0)

Global Hemophilia Market Report: 2016 Edition Research

PUNE, India, April 12, 2016 /PRNewswire/ --

MarketReportsOnline.com adds 2016 hemophilia market research report covering global, US and Europe hemophilia industry analysis while talking about Shire PLC, Bayer Group, Novo Nordisk and Pfizer Inc. as the major players in the industry.

Complete hemophilia market research of 52 pages with 47 Charts and 2 Tables, covering 4 major companies is now available in the pharmaceuticals category of MarketReportsOnline.com at http://www.marketreportsonline.com/463723.html .

The market is anticipated to be driven by key factors such as increasing penetration of recombinant factor VIII, increasing healthcare expenditure, emerging use of treatments in low income countries and increasing diagnosis rates. Some significant progresses of this industry include increasing adoption of prophylaxis therapy, introduction of extended half-life products etc. However, the growth of respective industry is faced by challenges such as high cost of treatments and high reluctance by patients to switch to new treatments/products.

The research report, "Global Hemophilia Market Report: 2016 Edition" provides a wide-ranging research and comprehensive analysis of the global hemophilia industry, along with a detailed study of its various regional markets such as the US the European market. It also discusses the major trends of the industry such as the development of gene therapy. The industry is highly competitive comprising a number of large companies including the Bayer Group, Shire Plc, Pfizer Inc, Novo Nordisk etc. Order a copy of this research at http://www.marketreportsonline.com/contacts/purchase.php?name=463723 .

The competitive landscape of the respective market, along with the company profiles of the leading players including companies' important growth strategies, business overview and financial position are also conferred for reference. The report is a must read for all those willing to invest in this area and trying to assess potential opportunities.

Even though Hemophilia is rare bleeding disorder, the number of people affected by it has been increasing with time. While mild hemophilia is easy to diagnose especially in kids, when they learn to move and walk, and get large bruises from minute falls, severe hemophilia patients need to go for periodic transfusion of the respective factors so as to avoid the event of life-threatening bleeding episodes. Such a periodic transfusion is done through what is commonly known as the replacement therapy. With increasing sophistication and modernization of technology, demand for advanced treatment options increases, thereby making the entire market grow.

For the healthcare and pharmaceutical decision makers, MarketReportsOnline.com offers another newly published research titled Global Constipation Market Report: 2016 Edition, which shows a vast opportunity for new drug entry. There exist vast opportunities for prescription drugs in the constipation market. However, OTC drugs and laxatives are generally used for treating constipation, patients and physicians have started recognizing the importance of branded drugs. Future growth of the constipation market is based on continued growth of prescription therapies to treat constipation, increased research and development of novel drugs by biopharmaceutical companies, increasing patient and physician awareness of effective prescription alternatives to Over-the-Counter medications.

Growth of the constipation market is driven by several factors including rising prescription opioid consumption, growing ageing population, vast opportunity for drugs with significant potential in the U.S., rising spending on medicines, growing female population and rising healthcare expenditure. However, the growth of the market can be hindered by certain challenges including rising tide of OTC drugs for constipation and lower awareness of prescription medication for OIC.

The report, "Global Constipation Market" analyzes the currently prevailing condition of the market along with its future scope of development. The specific markets of the U.S. Japan China and Europe are being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.

Comprehensive table of contents for this constipation market research is available at http://www.marketreportsonline.com/463724-toc.html .

Explore more reports on pharmaceuticals market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html .

About Us:

MarketReportsOnline.com is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage. Category focused research, country reports, company profiles, regional and global industry profiles and guides to premium reports offering extensive coverage of other 20+ industries are all available in our library of syndicated market research reports.

Contact Us:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com


Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.